Related Articles
Enhanced tumor retention of radioiodinated anti-epidermal growth factor receptor antibody using novel bifunctional iodination linker for radioimmunotherapy
Synergistic antitumor effect of the anti‑ErbB2 antibodies trastuzumab and H2‑18 on trastuzumab‑resistant gastric cancer cells
Concurrent biological targeting therapy of squamous cell carcinoma of the esophagus with cetuximab and trastuzumab
PROGNOSTIC VALUE OF P53 EXPRESSION IN EARLY-STAGE BREAST-CARCINOMA COMPARED WITH TUMOR ANGIOGENESIS, EPIDERMAL GROWTH-FACTOR RECEPTOR, C-ERBB-2, CATHEPSIN-D, DNA-PLOIDY, PARAMETERS OF CELL-KINETICS AND CONVENTIONAL FEATURES
ERBB2 and PTPN2 gene copy numbers as prognostic factors in HER2‑positive metastatic breast cancer treated with trastuzumab